Quell Therapeutics

Regcell

This biotechnology company develops regulatory T-cell therapies using an epigenetic reprogramming platform to treat patients with autoimmune diseases and inflammatory conditions.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

GentiBio

GentiBio develops engineered regulatory T cell therapies to restore immune tolerance for patients with autoimmune, alloimmune, autoinflammatory and allergic diseases.

Abata Therapeutics

This company develops regulatory T cell therapies to treat patients with severe autoimmune and inflammatory diseases including progressive multiple sclerosis and type 1 diabetes.

Autolus Therapeutics

This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.

Egle Therapeutics

This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.

Dualyx

This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.